-

Former Texas Instruments Executive Bing Xie Joins Huami's Board as Independent Director

BEIJING & CUPERTINO, Calif.--(BUSINESS WIRE)--Huami Corp. (NYSE: HMI) today announced that it appointed Mr. Bing Xie, former Texas Instruments (TI) executive officer and senior vice president of worldwide sales and applications, as an independent director on Huami’s board. Mr. Xie will serve on the board’s Audit, Compensation, Nominating, Corporate Governance and the AI and Big Data Ethics Committees.

Over a 21-year career at Texas Instruments, Mr. Xie most recently led the worldwide sales and applications teams. He was previously TI's president of Greater China (China, Taiwan, Hong Kong). Mr. Xie started his career at Hewlett-Packard, and later joined Bay Networks and 3Com. He has lived and worked in China, Italy, America and Canada. Mr. Xie holds a bachelor of science degree in electronics engineering from Xidian University, and an MBA from Clemson University.

“I am very happy that Mr. Bing Xie can join the board of directors,” said Wang Huang, chairman and CEO of Huami Corp. “He has extensive experience and global vision obtained from working with Texas Instruments. With his leadership, I believe he can help Huami better lay out the company's strategy toward the smart IOT industry, and further promote the implementation of our health and medical strategies."

Mr. Xie joins current standing board members Mr. De Liu, co-founder and a senior vice president of Xiaomi; Dr. Hongjiang Zhang, retired chief executive officer of Kingsoft (a Hong Kong listed company 03888.HK), former chief technology officer of Asia-Pacific R&D and Distinguished Scientist at Microsoft; Mr. Jimmy Lai, retired chief financial officer of China Online Education Group; Ms. Yunfen Lu, co-founder and vice president of Huami Corp.; and Mr. Xiaojun Zhang, co-founder and vice president of Huami Corp.

About Huami Corporation (NYSE: HMI)

Huami’s mission is to connect health with technology. Since its inception in 2013, Huami has developed a platform of proprietary technology including AI chips, biometric sensors, and data algorithms, which drive a broadening line of smart health devices for consumers, and analytics services for industry. In 2019, Huami shipped 37 million smart watches and fitness bands, including its own Amazfit brand, and products developed and manufactured for Xiaomi, comprising 23% of global category shipments1. Huami Corp is based in Hefei, China, with U.S. operations, Huami-USA, based in Cupertino, Calif.

For more information, please visit https://www.huami.com/investor/pages/company-profile

1 IDC, Correcting and Replacing Shipments of Wearable Devices, 3/10/20

Contacts

In China:
Investors: Grace Yujia Zhang, ir@huami.com
Media: Ken Cao, press@huami.com

In the United States:
Investors: Brad Samson, brad.samson@huami-usa.com, 714-955-3951
Media: Lydia Huang, lydia.huang@huami-usa.com, 407-800-5625

Huami Corporation

NYSE:HMI

Release Summary
Former Texas Instruments Executive, Bing Xie, Joins Huami's Board as Independent Director
Release Versions

Contacts

In China:
Investors: Grace Yujia Zhang, ir@huami.com
Media: Ken Cao, press@huami.com

In the United States:
Investors: Brad Samson, brad.samson@huami-usa.com, 714-955-3951
Media: Lydia Huang, lydia.huang@huami-usa.com, 407-800-5625

More News From Huami Corporation

Zepp Health Moves To AWS to Power Global Expansion

CUPERTINO, Calif.--(BUSINESS WIRE)--Zepp Health Corp. (NYSE: ZEPP) today announced that it has chosen to move the vast majority of its IT infrastructure to Amazon Web Services, Inc. (AWS), an Amazon.com company. Zepp Health is leveraging AWS’s global infrastructure, industry-leading security and compliance capabilities, and comprehensive suite of cloud services to drive its business strategy in more than 70 countries and support 38 million smart wearable device users worldwide. Zepp Health deve...

Zepp Health Expands Partnership with Rouumtech to Private-Label Custom Europa™ Portable X-ray System and Full Product Line in China

CUPERTINO, Calif. & GOYANG-SI, South Korea--(BUSINESS WIRE)--Zepp Health expands partnership with Rouumtech to private-label custom Europa™ portable X-ray system and full product line in China....

Huami Corp Invests $5 Million in Hyperfine Research D Round to Support Accelerated Application of Disruptive MRI Technology

BEIJING & CUPERTINO, Calif.--(BUSINESS WIRE)--Huami Corp. (NYSE: HMI) today announced that it has invested $5 million in Hyperfine Research’s D round of funding, which closed on February 3, 2021. Huami’s mission is to connect health with technology, developing both consumer and industrial health technologies. The company believes its miniaturization engineering expertise dovetails with efforts to miniaturize medical imaging technology which can disrupt the locations, applications and costs of m...
Back to Newsroom